cytarabine and bilirubin

cytarabine has been researched along with bilirubin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Atkinson, EN; Drewinko, B; Freedman, RS; Keeney, ED; Rutledge, FN1
Awoke, S; Dennis, DT; Doberstyn, EB; Renis, HE; Royer, GL1
Baccarani, M; Baraldo, M; Damiani, D; Ermacora, A; Fanin, R; Furlanut, M; Michieli, M; Pea, F; Russo, D; Zaja, F1
Bachy, E; Casasnovas, O; Freyer, G; Guitton, J; Hénin, E; Ribrag, V; Salles, G; Sebban, C; Tilly, H; Tod, M; You, B1
Feng, A; Masadeh, M; Murali, AR1

Trials

2 trial(s) available for cytarabine and bilirubin

ArticleYear
Failure of cytosine arabinoside in treating smallpox. A double-blind study.
    Lancet (London, England), 1974, Aug-17, Volume: 2, Issue:7877

    Topics: Adolescent; Adult; Aspartate Aminotransferases; Bilirubin; Blood Cell Count; Blood Proteins; Blood Urea Nitrogen; Child, Preschool; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Female; Humans; Injections, Intravenous; Male; Placebos; Smallpox

1974
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
    Leukemia, 1998, Volume: 12, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Chemotherapy, Adjuvant; Creatinine; Cyclosporine; Cytarabine; Feasibility Studies; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Treatment Outcome

1998

Other Studies

4 other study(ies) available for cytarabine and bilirubin

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Clinical evaluation of high-dose cytarabine and cisplatin in recurrent cervical carcinoma.
    Cancer treatment reports, 1985, Volume: 69, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Body Temperature; Cisplatin; Creatinine; Cyclophosphamide; Cytarabine; Drug Evaluation; Female; Humans; Leukocyte Count; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Time Factors; Uterine Cervical Neoplasms

1985
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carmustine; Creatinine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Serum Albumin; Transplantation, Autologous; Treatment Outcome; Young Adult

2015
Recurrent Isolated Hyperbilirubinemia From Drug-Induced Impaired Hepatic Bilirubin Uptake.
    Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:3

    Topics: Antimetabolites, Antineoplastic; Bilirubin; Chemical and Drug Induced Liver Injury; Cytarabine; Diagnosis, Differential; Female; Gilbert Disease; Humans; Hyperbilirubinemia; Leukemia, Myeloid, Acute; Liver; Medication Therapy Management; Patient Care Management; Young Adult

2020